Oligomerization of the Recombinant CD40L Increases Its Agonist Activity upon Stimulation of Human B Cells
Artem A. Mikhailov, Maria G. Byazrova, Maria M. Sukhova, Maxim V. Petukhov, Eleonora V. Shtykova, Alexander V. Filatov
Springer Nature ·
2026-09-01
· DOI 10.1134/s0006297926602133
The publisher did not provide an abstract — full text is available via the link below.
Artem A. Mikhailov, Maria G. Byazrova, Maria M. Sukhova, Maxim V. Petukhov, Eleonora V. Shtykova, Alexander V. Filatov. Oligomerization of the Recombinant CD40L Increases Its Agonist Activity upon Stimulation of Human B Cells. // Biochemistry (Moscow). – 2026. – DOI: 10.1134/s0006297926602133. – URL: https://doi.org/10.1134/s0006297926602133
Artem A. Mikhailov, Maria G. Byazrova, Maria M. Sukhova, Maxim V. Petukhov, Eleonora V. Shtykova, & Alexander V. Filatov (2026). Oligomerization of the Recombinant CD40L Increases Its Agonist Activity upon Stimulation of Human B Cells. Biochemistry (Moscow). https://doi.org/10.1134/s0006297926602133
Artem A. Mikhailov, et al. “Oligomerization of the Recombinant CD40L Increases Its Agonist Activity upon Stimulation of Human B Cells.” Biochemistry (Moscow), 2026. doi:10.1134/s0006297926602133.
@article{Mikhailov2026,
title = {Oligomerization of the Recombinant CD40L Increases Its Agonist Activity upon Stimulation of Human B Cells},
author = {Mikhailov, Artem A. and Byazrova, Maria G. and Sukhova, Maria M. and Petukhov, Maxim V. and Shtykova, Eleonora V. and Filatov, Alexander V.},
journal = {Biochemistry (Moscow)},
year = {2026},
doi = {10.1134/s0006297926602133},
url = {https://doi.org/10.1134/s0006297926602133}
}